Reducing the impact of viral respiratory infections in children.
This article reviews the epidemiology and clinical aspects of the major viral causes of upper and lower respiratory tract disease in children. Particular emphasis is placed on prevention and control of viral disease through the use of vaccines and antiviral agents. Evolution of new viral pathogens, such as avian influenza virus and the SARS-CoV, are discussed.
Meissner
H Cody
HC
Division of Pediatric Infectious Disease, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA. cmeissner@tufts-nemc.org
D017677:Age Distribution; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002669:Child Welfare / Q000706:statistics & numerical data; D002675:Child, Preschool; D003140:Communicable Disease Control / Q000458:organization & administration; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000517:prevention & control; D017281:Cost of Illness; D003937:Diagnosis, Differential; D019353:Endemic Diseases / Q000517:prevention & control / Q000706:statistics & numerical data; D005544:Forecasting; D006801:Humans; D007223:Infant; D009017:Morbidity; D020380:Needs Assessment; D011159:Population Surveillance; D011322:Primary Prevention / Q000458:organization & administration; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D014611:Vaccination; D014777:Virus Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology
D000998:Antiviral Agents